Castle biosciences forecasts fy2020 revenue between $61 million and $64 million

Castle biosciences announces fourth quarter and full-year 2019 results.q4 revenue $17.6 million versus $11.4 million.sees fy 2020 revenue $61 million to $64 million.q4 revenue estimate $11.7 million -- refinitiv ibes data.quarterly earnings per share $0.11.

CSTL Ratings Summary

CSTL Quant Ranking